RGS2 anticorps (N-Term)
-
- Antigène Voir toutes RGS2 Anticorps
- RGS2 (Regulator of G-Protein Signaling 2 (RGS2))
-
Épitope
- AA 4-32, N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp RGS2 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This RGS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 4-32 amino acids from the N-terminal region of human RGS2.
- Clone
- RB41808
- Isotype
- Ig Fraction
- Top Product
- Discover our top product RGS2 Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Date de péremption
- 6 months
-
-
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma." dans: Carcinogenesis, Vol. 31, Issue 10, pp. 1755-61, (2010) (PubMed).
: "
-
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
-
- Antigène
- RGS2 (Regulator of G-Protein Signaling 2 (RGS2))
- Autre désignation
- RGS2 (RGS2 Produits)
- Synonymes
- anticorps G0S8, anticorps GOS8, anticorps fa96c08, anticorps wu:fa96c08, anticorps wu:fj08f11, anticorps zgc:91965, anticorps g0s8, anticorps regulator of G protein signaling 2, anticorps regulator of G-protein signaling 2, anticorps regulator of G-protein signaling 2, 24kDa, anticorps regulator of G-protein signaling 2 L homeolog, anticorps RGS2, anticorps Rgs2, anticorps rgs2, anticorps rgs2.L
- Sujet
- Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis.
- Poids moléculaire
- 24382
- NCBI Accession
- NP_002914
- UniProt
- P41220
- Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
-